Ledger.Open graph →
SEC Form D · filed June 8, 2022

InMed Pharmaceuticals Inc

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
VANCOUVER, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Bryan J. Baldasare · Vancouver, British Columbia, CanadaDirectorMichael C. Woudenberg · Vancouver, British Columbia, CanadaExecEric C. Hsu · Vancouver, British Columbia, CanadaExecWilliam J. Garner · Vancouver, British Columbia, CanadaDirectorAdam A. Cutler · Vancouver, British Columbia, CanadaDirectorJanet J. Grove · Vancouver, British Columbia, CanadaDirectorAndrew J. Hull · Vancouver, British Columbia, CanadaDirectorAlexandra D. Mancini · Vancouver, British Columbia, CanadaExecEric A. Adams · Vancouver, British Columbia, CanadaExec · DirectorNaveen Singh · Bellevue, WADirectorPeter H. Diamandis, Md · Orlando, FLDirectorKenneth S. Cornick · Bellevue, WADirectorUtpal S. Donde · Bellevue, WAExecJeff S. Drummond · Bellevue, WAExecYuridia V. Rodriguez · Grand Rapids, MIDirectorCraig M. Hurlbert · Hamilton, MTExecPaul Kirchgraber · Broomfield, CODirectorBrenda A. Edwards · Vancouver, British Columbia, CanadaExecCharles King · Murfreesboro, TNDirectornull Dreavent Inc · Cambridge, MADirectorCharles Farguson · New York, NYExecAngela W. Strange · Cedar Falls, IADirectorRobert W. Smith, Jr · Cedar Falls, IAExecYosef A. Quint · Westwood, MAExecPetr G. Kilmo · Munsbach, LuxembourgDirectorMegan H. Pillsbury · Wilmington, DEDirectorEric A. Adams · Vancouver, British Columbia, CanadaExec · DirectorBrenda A. Edwards · Vancouver, British Columbia, CanadaExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗